NAVLE Multisystemic

Equine Hyperlipidosis (Donkeys) – NAVLE Study Guide

📅 March 28, 2026 ⏱ 25 min read

Hyperlipidosis (hyperlipemia/hyperlipaemia) is the most common metabolic disorder in donkeys and a life-threatening condition frequently tested on NAVLE.

Overview and Clinical Importance

Hyperlipidosis (hyperlipemia/hyperlipaemia) is the most common metabolic disorder in donkeys and a life-threatening condition frequently tested on NAVLE. It is characterized by abnormally elevated blood triglyceride concentrations resulting in multiorgan fat infiltration. Donkeys are uniquely predisposed due to evolutionary adaptation to harsh environments, making them extremely efficient at energy storage and mobilization. Unlike horses, donkeys cannot efficiently regulate fat mobilization during negative energy balance, leading to excessive triglyceride accumulation.

Prevalence ranges from 3-5% in general populations to 11-18% in hospitalized patients. Mortality rates remain high (43-80%) despite treatment, making early recognition and aggressive intervention essential.

High-YieldDonkeys are NOT small horses! They have inherent insulin resistance, higher baseline triglycerides (up to 150 mg/dL normal vs less than 50 mg/dL in horses), and uniquely efficient hepatic triglyceride synthesis. ANY sick or anorexic donkey should be considered at risk for hyperlipidosis.

Term	Definition
Hypertriglyceridemia	Elevated triglycerides greater than 100-200 mg/dL without visible lipemia
Hyperlipidemia	Triglycerides 200-500 mg/dL; no gross lipemia
Hyperlipemia (Clinical Disease)	Triglycerides greater than 500 mg/dL with visible lipemia (milky serum) and organ infiltration
Severe Hypertriglyceridemia	Greater than 1000-1200 mg/dL; associated with near 100% mortality
Hepatic Lipidosis	Fatty infiltration of liver causing hepatocyte dysfunction; most common organ affected

Key Terminology and Definitions

Board Tip - Memory Aid "DONKEY" for Risk Factors:

D = Dental disease (common trigger)

O = Obesity and Older age

N = Negative energy balance (anorexia)

K = Kicked/stressed (transport, social changes, companion loss)

E = Endocrine disorders (PPID, insulin dysregulation)

Y = Young foals and pregnant/lactating jennies at high risk

Characteristic	Clinical Significance
Inherent insulin resistance	Higher glucagon/insulin ratio predisposes to glucagon-driven lipolysis
Efficient hepatic metabolism	Liver rapidly converts FFAs to triglycerides; evolutionary adaptation
Higher baseline triglycerides	Normal donkey: up to 150-248 mg/dL vs. horses less than 50 mg/dL
Impaired lipolysis regulation	Cannot efficiently "turn off" fat mobilization; vicious cycle develops
Stoic temperament	Early signs subtle and easily missed; often advanced at presentation

Pathophysiology

Mechanism of Disease

During normal energy homeostasis, lipid metabolism is regulated by the balance between lipogenic hormones (insulin) and lipolytic hormones (glucocorticoids, catecholamines, ACTH, glucagon). When energy intake is adequate, insulin inhibits hormone-sensitive lipase (HSL) in adipose tissue, preventing excessive fat mobilization.

Increased HSL activity: Decreased insulin and/or insulin resistance leads to uninhibited hormone-sensitive lipase
Excessive lipolysis: Free fatty acids (FFAs) released at rates exceeding utilization capacity
Hepatic triglyceride synthesis: Liver re-esterifies FFAs into triglycerides as VLDLs (donkey liver uniquely efficient)
VLDL overproduction: When VLDL production exceeds peripheral clearance by lipoprotein lipase, blood triglycerides accumulate
Organ fatty infiltration: Excess triglycerides deposit in liver, kidneys, heart, pancreas, intestines, skeletal muscle
Multiorgan dysfunction: Leads to hepatic lipidosis, renal lipidosis, cardiac dysfunction, potentially hepatic rupture

Why Donkeys Are Uniquely Susceptible

Risk Factor	Mechanism	Clinical Notes
Anorexia/Inappetence	Negative energy balance triggers fat mobilization	ANY cause of reduced feed intake
Obesity (BCS greater than 6/9)	Increased fat stores and insulin resistance	Miniature donkeys: 10-20% prevalence
Female sex (Jennies)	Higher obesity rates; higher insulin levels	2x risk compared to males
Late pregnancy/Lactation	Increased energy demands; insulin resistance	Peak lactation = 87% higher energy needs
Concurrent disease	Cytokines, endotoxemia increase lipolysis	OR = 76.98 (HIGHEST risk factor)
Dental disease	Pain leads to inappetence	90% prevalence in older donkeys
Stress	Cortisol antagonizes insulin	Transport, social changes, companion loss
PPID (Cushing's)	Elevated ACTH; insulin resistance	Common in geriatric donkeys

Risk Factors and Predisposing Conditions

High-YieldConcurrent disease is the HIGHEST risk factor (OR = 76.98). Every sick donkey should be considered at risk for hyperlipidosis. Do NOT withhold food from donkeys before surgery - brief preoperative fasting (less than 12 hours) only.

Category	Triglyceride Level	Significance/Mortality
Normal (Donkey)	Less than 150-248 mg/dL	Higher than horses (less than 50 mg/dL)
Hyperlipemia Threshold	Greater than 500 mg/dL	Visible lipemia; clinical disease
Severe/Fatal	Greater than 1200 mg/dL	Near 100% mortality
Survivors vs Non-survivors	Mean: 9.3 vs 14.2 mmol/L	TG level correlates with outcome

Clinical Signs and Presentation

Clinical signs are often nonspecific and subtle, particularly in early stages. The stoic nature of donkeys means signs may be advanced at presentation.

Early Signs

Subtle behavioral changes: slightly dull, reduced interest
Reduced appetite: "sham" eating and drinking
Mild depression/lethargy: owner often first to notice

Progressive Signs

Complete anorexia: refuses all food including treats
Profound depression: head lowered, unresponsive
Weakness/trembling: reluctance to move
GI signs: mucus-covered dry fecal balls, diarrhea, colic
Halitosis: characteristic bad breath
Congested mucous membranes, tachycardia

Late/Severe Signs (Organ Failure)

Icterus (jaundice): yellow gums, sclera (hepatic dysfunction)
Neurological signs: head pressing, circling, ataxia, seizures (hepatoencephalopathy)
Ventral edema, oliguria/anuria, recumbency

NAVLE TipWhen NAVLE presents a donkey with depression, anorexia, and nonspecific signs - ALWAYS consider hyperlipidosis! Key clues: species (donkey/miniature), recent stress or illness, obesity, and "milky" or "opalescent" serum.

Component	Protocol	Notes
Fluid Therapy	Polyionic crystalloids with 5% dextrose; 50 mL/kg/day; add potassium (20-40 mEq/L)	Monitor for hyperglycemia
Nutritional Support (PRIMARY)	ENCOURAGE VOLUNTARY INTAKE: fresh grass, treats (ginger biscuits, apples, jam sandwiches)	Voluntary intake = best prognosis
Oral Drenching	1-2 g/kg dextrose in warm water; 50mL syringe 3-4x daily	Field treatment option
Flunixin Meglumine	0.25 mg/kg IV q6-12h (anti-endotoxic); 1.1 mg/kg if pyrexic	Anti-inflammatory
Anti-Ulcer Therapy	Omeprazole 4 mg/kg PO q24h; Sucralfate 10 mL PO q8-12h	Gastric ulcers common
Heparin (Controversial)	150 IU/kg loading; 125 IU/kg q8-12h SQ/IV	CONTRAINDICATED if coagulopathy
Treat Primary Disease	Address underlying cause: dental, colic, parasitism, PPID	ESSENTIAL for survival

Diagnosis

Diagnosis based on signalment, history, clinical signs, and gross observation of opalescent (milky/cloudy) serum or plasma. Visible lipemia is pathognomonic when triglycerides exceed 500 mg/dL.

Triglyceride Interpretation

Additional Laboratory Findings

GGT: Elevated (normal donkey up to 80 IU/L) - hepatic lipidosis
AST/SDH: Normal to elevated - hepatocyte damage
BUN/Creatinine: Variable; elevated with renal lipidosis (note: lipemia falsely increases creatinine)
Glucose: Variable; hyperglycemia with insulin resistance
PT/PTT: May be prolonged - hepatic synthetic dysfunction
Potassium: Hypokalemia common - secondary to anorexia

Gross Pathology (Necropsy)

Serum: Milky/opalescent
Liver: Pale, yellow-white, swollen, friable, greasy; may show rupture
Kidneys: Pale, swollen, friable

Favorable Indicators	Poor Indicators
Voluntary food intake maintained	Complete anorexia
TG less than 1000 mg/dL	TG greater than 1200 mg/dL (near 100% fatal)
Decreasing triglyceride trend	Static or increasing TG
Treatable primary disease	Neurological signs (hepatoencephalopathy)
Early detection	Renal failure (oliguria/anuria)

Treatment

Treatment must be prompt and aggressive. Goals: (1) treat underlying disease, (2) restore positive energy balance, (3) reduce fat mobilization, (4) supportive care.

NAVLE TipThe cornerstone of treatment is NUTRITIONAL SUPPORT to restore positive energy balance. Do NOT use corticosteroids - they worsen insulin resistance and fat mobilization.

Prognosis

Prognosis is guarded to poor with mortality rates of 43-80%. Aggressive treatment can reduce mortality to 0-33%.

Exam Focus - Memory Aid: "The 1200 Rule" - Peak triglyceride greater than 1200 mg/dL = fatal outcome. ALL miniature horses with TG greater than 1200 mg/dL died, while most with TG less than 1200 mg/dL survived.

Prevention and Management

Weight management: Maintain BCS 3/5; avoid obesity; gradual weight loss only
Regular monitoring: Monthly weighing; early detection of weight loss
Stress minimization: Slow changes; maintain social bonds; avoid separation
Dental care: Annual examinations
Preventive nutrition: Supplement any sick/at-risk donkey
Brief preoperative fasting only: Less than 12 hours; never prolong

Practice NAVLE Questions

Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.

Start Your Free Trial →

Equine Hyperlipidosis (Donkeys) &ndash; NAVLE Study Guide